Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,975 | 48 | 83.0% |
| Food and Beverage | $3,307 | 208 | 12.5% |
| Consulting Fee | $1,000 | 1 | 3.8% |
| Education | $196.12 | 6 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $16,024 | 75 | $0 (2023) |
| ABBVIE INC. | $8,368 | 67 | $0 (2024) |
| LEO Pharma Inc. | $388.98 | 30 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $264.94 | 15 | $0 (2021) |
| Janssen Biotech, Inc. | $254.08 | 10 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $202.63 | 11 | $0 (2024) |
| PFIZER INC. | $185.92 | 12 | $0 (2024) |
| Celgene Corporation | $105.75 | 6 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $79.99 | 1 | $0 (2022) |
| Galderma Laboratories, L.P. | $66.80 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,290 | 44 | ABBVIE INC. ($5,180) |
| 2023 | $4,380 | 34 | AbbVie Inc. ($2,975) |
| 2022 | $5,660 | 34 | Allergan, Inc. ($5,385) |
| 2021 | $8,193 | 28 | Allergan, Inc. ($8,035) |
| 2020 | $168.59 | 10 | Allergan, Inc. ($86.57) |
| 2019 | $1,662 | 38 | Allergan Inc. ($1,148) |
| 2018 | $375.01 | 26 | Janssen Biotech, Inc. ($64.91) |
| 2017 | $749.28 | 49 | Allergan Inc. ($177.91) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.92 | General |
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.99 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.50 | General |
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/14/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 11/08/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $499.75 | General |
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: DERMATOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.00 | General |
| 10/07/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $514.00 | General |
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/12/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $11.10 | General |
| 09/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Dermatology | ||||||
| 09/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $135.00 | General |
| 08/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.34 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $15.27 | General |
| 08/07/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $179.10 | General |
| 07/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.72 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,509 | 5,325 | $1.2M | $267,557 |
| 2022 | 22 | 3,549 | 5,496 | $1.3M | $282,845 |
| 2021 | 19 | 3,197 | 4,654 | $973,828 | $228,418 |
| 2020 | 18 | 2,615 | 3,826 | $601,359 | $171,331 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,221 | 1,617 | $485,100 | $100,560 | 20.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 516 | 656 | $196,800 | $54,418 | 27.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 498 | 613 | $147,120 | $25,729 | 17.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 230 | 250 | $75,000 | $17,179 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 128 | $48,000 | $11,063 | 23.0% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 29 | 36 | $24,300 | $11,027 | 45.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 209 | 241 | $72,300 | $9,669 | 13.4% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 29 | 36 | $14,400 | $7,742 | 53.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 343 | 1,338 | $50,175 | $6,998 | 13.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 94 | 94 | $35,250 | $6,025 | 17.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 31 | $13,950 | $4,373 | 31.3% |
| 10040 | Acne surgery | Office | 2023 | 42 | 44 | $7,700 | $3,447 | 44.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $6,372 | $2,159 | 33.9% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 12 | 12 | $5,040 | $1,787 | 35.5% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 13 | 16 | $4,800 | $1,277 | 26.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 17 | 17 | $5,100 | $1,231 | 24.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 28 | 39 | $5,558 | $1,214 | 21.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 19 | 22 | $6,600 | $880.13 | 13.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $3,150 | $709.56 | 22.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 31 | 103 | $2,549 | $71.75 | 2.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,245 | 1,712 | $513,600 | $105,257 | 20.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 537 | 730 | $219,000 | $61,446 | 28.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 500 | 660 | $158,400 | $27,514 | 17.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 193 | 212 | $63,600 | $14,896 | 23.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 150 | 150 | $56,250 | $11,676 | 20.8% |
About Dr. Katherine White, MD
Dr. Katherine White, MD is a Dermatology healthcare provider based in Northampton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043326937.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine White, MD has received a total of $26,478 in payments from pharmaceutical and medical device companies, with $5,290 received in 2024. These payments were reported across 263 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,975).
As a Medicare-enrolled provider, White has provided services to 12,870 Medicare beneficiaries, totaling 19,301 services with total Medicare billing of $950,151. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Northampton, MA
- Active Since 08/22/2006
- Last Updated 12/15/2009
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1043326937
Products in Payments
- BOTOX (Biological) $331.24
- ENSTILAR (Drug) $330.95
- COSENTYX (Biological) $264.94
- Sotyktu (Drug) $202.63
- EUCRISA (Drug) $141.92
- BOTOX COSMETIC (Biological) $120.44
- Otezla (Drug) $105.75
- TREMFYA (Drug) $103.51
- Skyrizi (Biological) $103.38
- DUPIXENT (Biological) $99.97
- Tremfya (Drug) $96.52
- RINVOQ (Biological) $55.91
- ADBRY (Biological) $53.53
- EPIDUO FORTE (Drug) $52.29
- Cimzia (Drug) $48.87
- Humira (Biological) $45.09
- CIBINQO (Drug) $44.00
- STELARA (Biological) $39.36
- ILUMYA (Biological) $39.23
- DUPIXENT (Drug) $34.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.